Discover a Unique Business Opportunity with I Quit Smoking India – A Path to Proud Returns!
Are you seeking a business venture that not only offers impressive returns on investment but also fills you with pride? Read on to explore the unique model offered by I Quit Smoking India (IQS)!
The Smoking Epidemic: A Global Concern: Smoking is a grave concern, claiming the lives of six individuals every minute due to smoking-related illnesses. According to the World Health Organization, one-third of the world’s population smokes, amounting to over 15 billion cigarettes consumed globally each day. IQS recognizes this staggering market, encompassing 1.3 billion smokers, and is poised to make a significant impact.
IQS’ Unparalleled Success: IQS boasts an exceptional success rate of up to 90%, setting a new industry standard in smoking cessation. Our patented technology, extensive franchise network, and management expertise place us miles ahead of competitors in the market.
Franchise Facts:
Comprehensive Training for Success: Our franchisees undergo comprehensive training to master the implementation and application of our program, including:
Marketing and Support: IQS franchisees benefit from extensive marketing and advertising support to attract customers to their centers and educate potential franchisees. We provide a range of materials, from marketing strategies and templates to corporate identity materials and collateral, accessible through our Franchisee Extranet.
Join the Revolution – Be Your Own Boss with IQS: Step into the world of IQS as a franchisee and embark on a journey of financial success and personal pride. Don’t miss this opportunity – act now!
Warm Regards,
The I Quit Smoking India Team
Accepting franchise applications in 32 states & UTs
Disclaimer: All scores, rankings, and estimates on ForeFind are independently produced editorial assessments using publicly available data and validated brand-submitted information. They are not verified facts, financial advice, or investment recommendations. Full Disclaimer.